Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Bradley Hill Holdings Continue Biotech Division Expansion

Abstract:
In a speech delivered to Investors recently in Singapore, James Elliot; a senior partner in Hong Kong-based Venture Capital Firm Bradley Hill Holdings Ltd announced plans to expand their successful Biotech/Life Sciences division.

Bradley Hill Holdings Continue Biotech Division Expansion

Hong Kong, China | Posted on December 3rd, 2008

Elliot, who has been with Bradley Hill for over 10 years now, said that they would be utilizing "a global network of established partners and affiliates to keep our finger on the pulse of Research and Development in the Biotechnology field."

Bradley Hill Holdings are believed to be involved with a select number of hand-picked startup enterprises who have what the firm's associates say are "FDA-Approval failsafes". The common focus of these enterprises is said to be nanotechnology - with a particular eye on products being offered to the ever-growing medical services sector. Indeed, with the baby-boomer trend causing an ever-increasing average age in humans, this strategy is seen by many to be another example of Bradley Hill showing a level of forward thinking that sets top-tier VC firms apart from the crowd.

Little is known of Bradley Hill Holdings current projects, due to stringent non-disclosure agreements which are put in place to protect the integrity of their clients, as yet unpatented products and technologies, but they are well known for their private funding of many successful startups, as well as proving business development and go-to-market planning skills to firms who are often comprised of primarily academic & scientific minds.

####

About Bradley Hill Holdings Ltd
Bradley Hill Holdings were formed in 1981 and have been growing constantly since their formation, due in no large part to a handful of successful partnerships with dot-com wonderkids of the early-nineties and more recently, far-eastern biotech gurus, who have then gone on to sell out to industry kingpins such as GSK and Pfizer for astronomical gains.

Copyright © Bradley Hill Holdings Ltd

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Philadelphia Mathematician Robert Clark Turns to Crowdfunding to Support Nanotechnology Research That Could Lead to ‘Flying’ Cars and Space Elevator April 4th, 2016

Harris & Harris Group Announces Formation of Co-Investment Fund for Accredited Investors March 9th, 2016

Clinatec Announces €30M Fundraising Campaign to Speed Research In Treatment of Neurodegenerative Diseases, Cancer and Motor Disabilities February 24th, 2016

Nanomedicine

Nanoparticles hold promise as double-edged sword against genital herpes April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

JPK reports on the use of a NanoWizard AFM system at the University of Kaiserslautern to study the interaction of bacteria with microstructured surfaces April 28th, 2016

Announcements

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic